# Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

> **NCT00001893** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 150 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TNFR:Fc

## Key facts

- **NCT ID:** NCT00001893
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08-17
- **Primary completion:** 2002-12-31
- **Final completion:** —
- **Target enrollment:** 150 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001893, "Study of TNFR:Fc (Enbrel) in the Treatment of Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*